The results showed that IGF2BP3 was overexpressed in bladder cancer tissues compared with that in normal bladder tissues, and its higher expression was closely correlated with poor prognosis in bladder cancer patients. This evidence concerns the gene IGF2BP3 and urinary bladder carcinoma.